Plasma Biomarkers for Neurodegenerative Disease What Clinicians Need to Know in 2026 Review Key Takeaways Plasma biomarkers are rapidly transforming the diagnosis and management of Alzheimer’s disease and related dementias, representing one of the most notable advances in neurodegenerative medicine in recent decades. Historically, the definitive assessment of Alzheimer’s pathology has
Tag: GFAP
Breakthrough: New Alzheimer’s Disease Research Shows Prevention Potential in Clinical Trials
Breakthrough: New Alzheimer’s Disease Research Shows Prevention Potential in Clinical Trials Please like and subscribe if you enjoyed this video :-) Introduction Recent Alzheimer’s disease research reveals a substantial shift from treatment to prevention strategies, offering new hope for millions worldwide. Clinical
